# Dexpramipexole Japanese PK Study

> **NCT01424163** · PHASE1 · COMPLETED · sponsor: **Knopp Biosciences** · enrollment: 57 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Single dose reduced
- **DRUG:** Single dose standard
- **DRUG:** Multiple Dose
- **DRUG:** Multiple Dose

## Key facts

- **NCT ID:** NCT01424163
- **Lead sponsor:** Knopp Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2021-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424163, "Dexpramipexole Japanese PK Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01424163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*